Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)’s Beam Therapeutics BEAM Stock Holding History

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$755K	Sell	22,000 -16,000	-42%	-$483K	0.3%	92
2026 Q1	$906K	Sell	38,000 -7,000	-16%	-$194K	0.47%	69
2025 Q4	$1.25M	Sell	45,000 -6,000	-12%	-$153K	0.61%	53
2025 Q3	$1.24M	Hold	51,000	–	–	0.66%	51
2025 Q2	$868K	Buy	51,000 +6,000	+13%	+$104K	0.45%	64
2025 Q1	$879K	Buy	45,000 +3,000	+7%	+$78.6K	0.56%	58
2024 Q4	$1.04M	Hold	42,000	–	–	0.6%	58
2024 Q3	$1.03M	Hold	42,000	–	–	0.65%	58
2024 Q2	$984K	Buy	+42,000	New	+$1.03M	0.64%	56

Other funds holding BEAM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

CGH

Contrarius Group Holdings Hamilton, Bermuda $2.17B AUM 134.87% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s BEAM Position: Q2 2026 in Review

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) reduced its Beam Therapeutics (BEAM) stake by 42% in Q2 2026, selling an estimated $483K and leaving 22,000 shares worth $755K. The position accounts for 0.3% of the portfolio, ranked #92.

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) first reported a position in BEAM in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.25M in Q4 2025. 168 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) held 22,000 shares of Beam Therapeutics worth $755K as of Q2 2026.
Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) sold 16,000 Beam Therapeutics shares in Q2 2026, an estimated $483K.
Beam Therapeutics made up 0.3% of Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s portfolio in Q2 2026, its #92 holding.
Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) first reported a position in Beam Therapeutics in Q2 2024 and has held it in 9 quarters since.
Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s Beam Therapeutics position peaked at $1.25M in Q4 2025.
168 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s 13F filing for Q2 2026, filed 22 Jul 2026.